Clinical Trials Browser

Phase 1 × Carcinoma, Renal Cell × HDAC-42 × Clear all

NCT02795819 2019-10-24

Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer

Phase 1 Terminated

6 enrolled 12 charts

GenitourinarySarcoma

Carcinoma, Renal Cell, Neoplasm Metastasis, Sarcoma